DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific

Dayton J. Goodell, Vincent Zaegel, Steven J. Coultrap, Johannes Hell, K. Ulrich Bayer

Cell Reports · 2017 · 86 citations · 52 references

DOIFull text

Open access

Concepts

Abstract

/CaM results in synaptic DAPK1 removal during LTP but retention during LTD. A pharmacogenetic approach showed that suppression of CaMKII/GluN2B binding is a DAPK1 function required for LTD.

References

52